The aim of the study was to evaluate the diagnostic and prognostic role of antibodies against pneumococcal capsular polysaccharide (anti-PCP) and natural anti-Gal antibodies in CLL patients with secondary antibody deficiencies and patients with CVID. The gene discussed is GAL; the disease is pneumocystosis.